A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ST / sulfamethoxazole-trimethoprim

[Related PubMed/MEDLINE]
Total Number of Papers: 47
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ST  (>> Co-occurring Abbreviation)
Long Form:   sulfamethoxazole-trimethoprim
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Clarithromycin As an Alternative and Prophylactic Agent in a Hematopoietic Stem Cell Transplantation Patient. GVHD, HSCT
2021 Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases. CTD-PCP, DPC, ILD
2020 Fate and seasonal change of Escherichia coli resistant to different antibiotic classes at each stage of conventional activated sludge process. AMX, ARB, CIP, KM, NFX, TC, WWTPs
2018 Cerebral Toxoplasmosis Diagnosed by Nested-polymerase Chain Reaction in a Patient with Rheumatoid Arthritis. PCR, RA
2017 A study on the colonization of Pneumocystis jirovecii among outpatients during cancer chemotherapy and among healthy smokers. PCP, PJ
2017 Pneumocystis Pneumonia in Non-HIV Pregnant Women Receiving Chemotherapy for Malignant Lymphoma: Two Case Reports. HIV, PCP
2016 Synergistic effects of resveratrol (free and inclusion complex) and sulfamethoxazole-trimetropim treatment on pathology, oxidant/antioxidant status and behavior of mice infected with Toxoplasma gondii. ---
2015 Effects of sulfamethoxazole-trimethoprim associated to resveratrol on its free form and complexed with 2-hydroxypropyl-beta-cyclodextrin on cytokines levels of mice infected by Toxoplasma gondii. HP-beta-CD, p.i
2015 Sulfamethoxazole-trimethoprim associated with resveratrol for the treatment of toxoplasmosis in mice: Influence on the activity of enzymes involved in brain neurotransmission. AChE, AK, CK, PK
10  2015 [Case Report: Clindamycin with Primaquine Therapy for Severe Pneumocystis Pneumonia]. PCP, POD
11  2014 Diphenyl diselenide and sodium selenite associated with chemotherapy in experimental toxoplasmosis: influence on oxidant/antioxidant biomarkers and cytokine modulation. AOPP, GR, p.i, TBA
12  2014 Primary brain abscess caused by Nocardia otitidiscaviarum. ---
13  2014 Susceptibility of various oral antibacterial agents against extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae. CETB, CL, CLSI, ESBL, FOM, FRPM, LVFX, MINO, STFX
14  2013 The first case report of peritoneal dialysis related peritonitis caused by Microbacterium paraoxydans. EM, PD
15  2011 [Pulmonary nocardiosis with elevation of serum beta-D-glucan in a patient with polymyositis]. GGOs
16  2009 [Examination of availability of the criteria for protective therapy against Pneumocystis pneumonia]. DM, IP, MCTD, PCP, PN, RA, RPGN, SjS, SLE, SSc
17  2008 Increased incidence of interstitial pneumonia by CHOP combined with rituximab. IP, R-CHOP
18  2008 [A complicated case of Nocardia brain abscess for differential diagnosis]. CT, MINO, MRI, NAA
19  2008 [Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation]. CAM, FHL, MINO, NTM, uCBSCT
20  2007 Antimicrobial susceptibility of community-acquired uropathogens in general practice. ---
21  2005 [Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)]. ABK, BIVR, MINO, PZFX, RFP, TEIC, VCM
22  2004 [Nocardial brain abscess: surgery and postoperative antibiotic therapy]. MINO
23  2004 [The trend and susceptibility to antibacterial agents of enterococcus species from urinary tract infections]. CPR, CZOP, IPM/CS, LVFX, MINO, VCM, VRE
24  2003 [Report of questionnaire survey for methicillin-resistant Staphylococcus aureus and penisillin-resistant Streptococcus pneumoniae between 1998 and 2000 in the Kinki district]. ABK, MRSA, PRSP, TEIC, VCM
25  2002 [Pulmonary complications in patients with AIDS]. CMV, HAART, LDS, MAC, PCP, PI
26  2000 Efficacy of sulfamethoxazole-trimethoprim administration in the prevention of Pneumocystis carinii pneumonia in patients with connective tissue disease. CTD, PCP
27  2000 [A case report of pulmonary nocardiosis successfully treated with a combination of sulfamethoxazole-trimethoprim (ST) and sparfloxacin]. ---
28  1999 [A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-negative bacilli]. AMK, CMZ, FOM, GM, LMOX, MINO
29  1999 [A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-positive cocci and gram-negative cocci]. CCL, CMZ, LMOX, MINO, OFLX, VCM
30  1999 [Report of questionnaire survey for methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae in the Kinki District]. GM, MINO, MRSA, PRSP, VCM
31  1998 A randomized controlled trial of sulfamethoxazole/trimethoprim plus norfloxacin versus sulfamethoxazole/trimethoprim alone for the prophylaxis of bacteria infection during chemotherapy for lung cancer. NFLX
32  1998 [An epidemiological investigation for MRSA and PRSP in Kinki area. Kinki Infection Working Group]. MRSA, PRSP, VCM
33  1996 [A possibility of therapeutic trial with tetrahydrobiopterin, which was suggested by the administration of sulfamethoxazole-trimethoprim]. CSF
34  1996 [Antibiotic resistance of clinical isolates Streptococcus pneumoniae]. CLDM, EM, MINO, OFLX
35  1995 Sulfamethoxazole-trimethoprim double-blind, placebo-controlled, crossover trial in Machado-Joseph disease: sulfamethoxazole-trimethoprim increases cerebrospinal fluid level of biopterin. CSF, MJD
36  1995 [Nationwide survey on susceptibilities of clinical isolates to antibacterial agents in 1991]. AMK, AZT, CAZ, GM, IPM, LMOX, OFLX, PIPC, TOB
37  1993 [Clinicopathological study of 10 cases of Pneumocystis carinii pneumonia]. PCP, TBLB
38  1991 Effect of sulfamethoxazole-trimethoprim and sulfadoxine-primethamine against fatal pneumocystosis in SCID mice. PC, SCID, SP
39  1991 [Species and serovar distribution, and drug resistance of Shigella strains isolated from imported and domestic cases in 1980-1989 in Tokyo]. CP, FOM, KM, NA, NFLX, SM, TC
40  1990 [A case of pulmonary nocardiosis associated with middle lobe atelectasis]. MINO, NTL
41  1990 [Biochemical characteristics, growth on selective media, antimicrobial susceptibility, and diarrheagenic toxin production of enteroinvasive Escherichia coli]. CP, DHL, EIEC, FOM, KM, NA, NFLX, SM, SS, TC
42  1990 [Clinical studies on chronic prostatitis and prostatitis-like syndrome. (3). Clinical re-examination of chronic bacterial prostatitis using the criteria for clinical evaluation]. ---
43  1989 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution]. CMX, CTM, GM, IPM, LMOX, MIC90, OFLX, PIPC
44  1988 [Studies on nephrotoxicity of cyclosporin. II. Nephrotoxicity in rats receiving cyclosporin and sulfamethoxazole-trimethoprim]. BUN, CS, NAG, SMX, TMP
45  1987 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). I. Susceptibility distribution]. AZT, CCL, CEZ, CFX, CMX, CMZ, CPZ, CRMN, CTM, CTX, CZX, LMOX, NA, OFLX, PPA
46  1985 Adverse reaction to sulphonamides in a burned patient--a case report. ---
47  1983 Prophylactic antimicrobial treatment in transurethral prostatectomy. How long should it be instituted? ---